DelmezJ.A., SlatopolskyE.Recent advances in the pathogenesis and therapy of uremic secondary hyperparathyroidism.J Clin Endocrinol Metab1991; 72: 735–9.
2.
Lopez-HilkerS., DussoA., RappN., MartinK.J., SlatopolskyE.Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol.Am J Physiol1990; 259: F4327.
3.
LucasP.A., BrownR.C., WoodheadJ.S., ColesG.A.1,25–dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: Effects of simultaneous protein and phosphorus restriction.Clin Nephrol1986; 25: 7–10.
4.
GalceranT., MartinK.J., MorrisseyJ.J., SlatopolskyE.The role of 1,25(OH)2D3 on the pathogenesis of skeletal resistance to parathyroid hormone in chronic renal failure.Kidney Int1987; 32: 801–7.
5.
RodriguezM., Martin-MaloA., MartinezM.E., TorresA., FelsenfeldA.J., LlachF.Calcemic response to parathyroid hormone in renal failure: Role of phosphorus and its effect on calcitriol.Kidney Int1991; 40: 1055–62.
6.
BrownE.M., WilksonR.E., EastmanR.C., PallottaJ., MarynickS.P.Abnormal regulation of parathyroid hormone release by calcium in secondary-hyperparathyroidism due to chronic renal failure.J Clin Endocrinol Metab1982; 54: 172–9.
7.
CantleyL.K., RussellJ., LettieriD., SherwoodL.M.1,25 dihydroxyvitamin D3 suppresses parathyroid hormone secretion from parathyroid cells in tissue culture.Endocrinology1985; 117: 2114–9.
8.
SilverJ., RussellJ., SherwoodL.M.Regulation by vita min D metabolites of messenger RNA for pre-proparathyroid hormone in isolated bovine parathyroid cells.Proc Natl Acad Sci USA1985; 82: 4270–3.
9.
RussellJ., LettieriD., SherwoodL.M.Suppression by 1,25(OH)2D3 of transcription of the parathyroid hormone gene.Endocrinology1986; 119: 2864–6.
10.
SilverJ., Naveh-ManyT., MauerH., SchmeizerH.J., PopovtzerM.M.Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo by the rat.J Clin Invest1986; 78: 1296–301.
11.
OkazakiT., IgarashiT., KronenbergH.M.5′-Flanking region of the parathryoid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3.J Biol Chem1988; 263: 2203–8.
12.
SlatopolskyE., WeertsC., ThielanJ., HorstR., HarterH., MartinK.J.Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy cholecalciferol in uremic patients.J Clin Invest1984; 74: 2136–43.
13.
DelmezJ.A., TindiraC., GroomsP., DussoA., WindusD.W., SlatopolskyE.Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D: A role for increased sensitivity to calcium.J Clin Invest1989; 83: 1349–55.
14.
DunlayR., RodriguezM., FelsenfeldA.J., LlachF.Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis.Kidney Int1989; 36: 1093–8.
15.
MalbertiF., SurianM., CosciP.Effect of chronic intravenous calcitriol on parathyroid function and set point of calcium in dialysis patients with refractory secondary hyperparathyroidism.Nephrol Dial Transplant1992; 7: 822–8.
16.
SaluskyI., FineR., KangarlooH.“High-dose” calcitriol for control of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.Kidney Int1987; 32: 89–95.
17.
DelmezJ.A., DouganC.S., GearingB.K.The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.Kidney Int1987; 31: 795–9.
18.
MartinK.J., BallalH.S., DomotoD.T., BlalockS., WeindelM.Pulse oral calcitriol for the treatment of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis: Preliminary observations.Am J Kidney Dis1992; 19: 540–5.
19.
TsukamotoY., NomuraM., TakahashiY.The “oral 1,25–dihydroxyvitamin D3 pulse therapy’ in hemodialysis patients with severe secondary-hyperparathyroidism.Nephron1991; 57: 23–8.
20.
SchaeferK., UmlaufE., van HerrathD.Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.Am J Kidney Dis1992; 19: 460–4.
21.
SelgasR., MartinezM.E., MirandaB.Pharmacokinetics of a single dose of calcitriol administered subcutaneously in CAPD patients.Perit Dial Int1993; 13: 122–5.
22.
RollaR., PaolettE., MarsanoL., MulasD., PelosoG., CanellaG.Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in CAPD uremic patients.Perit Dial Int1993; 13: 118–21.
23.
PeiY., HerczG., GreenwoodC.Non-invasive prediction of aluminum bone disease in hemo and peritoneal dialysis patients.Kidney Int1992; 41: 1374–82.
